Fight Over Waze? Way
Health Care: Drugs
Trinity Biotech PLC (TRIB: NASDAQ)
$17.34 0.49 | 2.91%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 17.34 |
| 52 Week High | 19.00 |
| 52 Week Low | 10.89 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 0.56 |
| Share Related Items | |
| Mkt Cap (Mil) | 385.79 |
| Shares Out (Mil) | 22.25 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.90 |
| Annual Dividend | 0.15 |
| Payout Ratio | 19.00 |
| Financial Strength | |
| Quick Ratio | 6.20 |
| Current Ratio | 7.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 22.60 |
| Price/Sales | 4.66 |
| Price/Book | 2.21 |
| Price/Cash Flow | 15.90 |
| Per Share Data | |
| Earnings | 0.77 |
| Sales | 3.72 |
| Book Value | 7.85 |
| Cash Flow | 1.09 |
| Business Summary | |
|---|---|
| Trinity Biotech PLC develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. | |
| General Information | |
| IDA Business Park
Bray, Co. Wicklow, |
|
| www.trinitybiotech.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 394 | |
| CEO: Ronan O'Caoimh | |
| Short Interest | |
| Current Month (Mil) | 0.08 |
| Previous Month (Mil) | 0.09 |
| Short Interest Ratio (Days) | 1.20 |
| Management Effectiveness | |
| Return on Equity | 12.30 |
| Return on Assets | 10.60 |
| Return on Investments | 12.30 |
| Profitability | |
| Gross Margin | 51.00 |
| EBIT Margin | 19.70 |
| Profit Margin | 26.00 |
Portfolios with TRIB
- Portfolio NameUser Type
- ContributorHighest-Yielding Drug Stocks
- ContributorTop-Rated Health Care Equip...
- UserLA
- UserFANTASTIC FIVE !!!
- UserSUPRATRADE-Top-Performing C...
- UserSUPRATRADE-2205101129
- UserIHUG2
- Userann's prorfolio
- Userpmaharg Portfolio 1
- Userrick weitz Portfolio 1
Latest TRIB Headlines from TheStreet
- Trinity Biotech Announces Quarter 1 Results - EPS Of 20 Cents, Premier Regulatory Approval In China And 33% Increase In Dividend To 20 Cents 04.25.13 | 08:04 am
- Trinity Biotech Becomes Oversold (TRIB) 04.24.13 | 12:04 pm
- Trinity Biotech Plc To Announce First Quarter Fiscal Year 2013 Financial Results 04.16.13 | 05:04 am
- Trinity Biotech Announces Results For Fiscal Year 2012 03.05.13 | 07:03 am
- Trinity Biotech Plc To Announce Fourth Quarter And Fiscal Year 2012 Financial Results 02.20.13 | 11:02 am
- Trinity Biotech Announces Quarter 3 Financial Results 10.18.12 | 08:10 am
- Trinity Biotech Plc To Announce Third Quarter Fiscal Year 2012 Financial Results 10.04.12 | 05:10 am
- Trinity Biotech PLC Stock Upgraded (TRIB) 03.04.11 | 05:03 pm
- Citigroup Finally Downgrades Homebuilders
07.02.07 | 01:07 pm - Wall St. Confidential: Cramer Says There's No Way Out for NY Times 06.15.07 | 02:06 pm
Press Releases for TRIB
Partner Headlines for TRIB
- Trinity Biotech - Momentum - Zacks 08.03.12 | 01:08 am
- Target OPENING 135 Stores and 4 Stocks on 52-Week Highs - Wall St. Cheat Sheet 07.13.12 | 10:07 am
- Pre-Market Earnings Report for July 12, 2012 : FAST, CBSH, NG, TRIB, MTOX - NASDAQ 07.11.12 | 08:07 pm
- Trinity Biotech Q4 Results Miss But Revenue Growth Guidance In Line - Seeking Alpha 03.07.12 | 09:03 am
- Trinity Biotech (TRIB) - Bull of the Day - Zacks 03.09.11 | 01:03 am
- Trinity Biotech Shares Remain Undervalued: Revising Our 2011 Outlook / Price Target - Seeking Alpha 03.08.11 | 08:03 am
- Reviewing the Year-to-Date Performance of Irish ADRs - Seeking Alpha 11.26.10 | 11:11 am
- Trinity Biotech: Initiated at Outperform - Analyst Blog - Zacks 05.12.10 | 04:05 pm
